Forte Biosciences (FBRX) Non-Current Deffered Revenue (2016 - 2019)

Forte Biosciences (FBRX) has 4 years of Non-Current Deffered Revenue data on file, last reported at $2.3 million in Q1 2019.

• On a quarterly basis, Non-Current Deffered Revenue rose 8414.81% year-over-year to $2.3 million in Q1 2019; TTM through Mar 2019 was $2.3 million, a 8414.81% increase from a year earlier, with the FY2018 full-year figure at $2.2 million, up 6013.89% from the prior year.
• Non-Current Deffered Revenue for Q1 2019 stood at $2.3 million, up from $2.2 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for FBRX reached as high as $2.3 million in Q1 2019 and fell as low as $27000.0 in Q1 2018.
• Historically, Non-Current Deffered Revenue has averaged $836100.0 across 4 years, with a median of $64500.0 in 2016.
• Across the five-year window, Non-Current Deffered Revenue tumbled 55.74% in 2018 and soared 8414.81% in 2019, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $68000.0 in 2016, then tumbled by 47.06% to $36000.0 in 2017, then surged by 6013.89% to $2.2 million in 2018, then grew by 4.45% to $2.3 million in 2019.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $2.3 million in Q1 2019, $2.2 million in Q4 2018, and $2.0 million in Q3 2018.